130 related articles for article (PubMed ID: 31769844)
21. Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.
Lee JC; Pekmezci M; Lavezo JL; Vogel H; Katznelson L; Fraenkel M; Harsh G; Dulai M; Perry A; Tihan T
Endocr Pathol; 2017 Dec; 28(4):287-292. PubMed ID: 28994039
[TBL] [Abstract][Full Text] [Related]
22. [Neurosurgery and pituitary tumors: etio-pathogenic considerations].
Visot A
Presse Med; 2001 Mar; 30(8):392-4. PubMed ID: 11268900
[TBL] [Abstract][Full Text] [Related]
23. Nonfunctioning Pituitary Adenomas Are Really Clinically Nonfunctioning? Clinical and Endocrinological Symptoms and Outcomes with Endoscopic Endonasal Treatment.
Yildirim AE; Sahinoglu M; Ekici I; Cagil E; Karaoglu D; Celik H; Nacar OA; Belen AD
World Neurosurg; 2016 Jan; 85():185-92. PubMed ID: 26344636
[TBL] [Abstract][Full Text] [Related]
24. Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis.
Jahangiri A; Wagner JR; Han SW; Tran MT; Miller LM; Chen R; Tom MW; Ostling LR; Kunwar S; Blevins L; Aghi MK
J Neurosurg; 2016 Mar; 124(3):589-95. PubMed ID: 26252454
[TBL] [Abstract][Full Text] [Related]
25. Gonadotroph cell pituitary adenomas.
Snyder PJ
Endocrinol Metab Clin North Am; 1987 Sep; 16(3):755-64. PubMed ID: 3319601
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas.
Dogansen SC; Yalin GY; Tanrikulu S; Tekin S; Nizam N; Bilgic B; Sencer S; Yarman S
Pituitary; 2018 Aug; 21(4):347-354. PubMed ID: 29460202
[TBL] [Abstract][Full Text] [Related]
27. Pituitary tumor type affects the chance of biochemical remission after radiosurgery of hormone-secreting pituitary adenomas.
Pollock BE; Brown PD; Nippoldt TB; Young WF
Neurosurgery; 2008 Jun; 62(6):1271-6; discussion 1276-8. PubMed ID: 18824993
[TBL] [Abstract][Full Text] [Related]
28. High prevalence rate of pituitary incidentaloma: is it associated with the age-related decline of the sex hormones levels?
Kastelan D; Korsic M
Med Hypotheses; 2007; 69(2):307-9. PubMed ID: 17280790
[TBL] [Abstract][Full Text] [Related]
29. Radiation therapy in the multimodal treatment approach of pituitary adenoma.
Becker G; Kocher M; Kortmann RD; Paulsen F; Jeremic B; Müller RP; Bamberg M
Strahlenther Onkol; 2002 Apr; 178(4):173-86. PubMed ID: 12040754
[TBL] [Abstract][Full Text] [Related]
30. Pediatric pituitary adenomas.
Mindermann T; Wilson CB
Neurosurgery; 1995 Feb; 36(2):259-68; discussion 269. PubMed ID: 7731505
[TBL] [Abstract][Full Text] [Related]
31. Neuronal differentiation and expression of neural epitopes in pituitary adenomas.
Johnson MD; Fan X; Bourne P; Walters D
J Histochem Cytochem; 2007 Dec; 55(12):1265-71. PubMed ID: 17875653
[TBL] [Abstract][Full Text] [Related]
32. Experiences of and barriers to transition-related healthcare among Korean transgender adults: focus on gender identity disorder diagnosis, hormone therapy, and sex reassignment surgery.
Lee H; Park J; Choi B; Yi H; Kim SS
Epidemiol Health; 2018; 40():e2018005. PubMed ID: 29514430
[TBL] [Abstract][Full Text] [Related]
33. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
[TBL] [Abstract][Full Text] [Related]
34. Free alpha-subunit and intact TSH secretion in vitro are closely associated in human somatotroph adenomas.
Aylwin SJ; King A; Blenke A; Geddes JF; Wood DF; Monson JP; Burrin JM
Eur J Endocrinol; 1998 Oct; 139(4):378-86. PubMed ID: 9820613
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical Evaluation of Canine Pituitary Adenomas Obtained by Transsphenoidal Hypophysectomy.
Miller MA; Owen TJ; Bruyette DS; Scott-Moncrieff JC; Ramos-Vara JA; Weng HY; Chen AV; Martin LG; DuSold DM
Vet Pathol; 2018 Nov; 55(6):889-895. PubMed ID: 29925292
[TBL] [Abstract][Full Text] [Related]
36. Pituitary prolactin-secreting tumor formation: recent developments.
Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF
Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432
[TBL] [Abstract][Full Text] [Related]
37. Pituitary apoplexy of a gonadotroph adenoma following gonadotrophin releasing hormone agonist therapy for prostatic cancer.
Reznik Y; Chapon F; Lahlou N; Deboucher N; Mahoudeau J
J Endocrinol Invest; 1997 Oct; 20(9):566-8. PubMed ID: 9413812
[TBL] [Abstract][Full Text] [Related]
38. Human pituitary somatotroph adenoma and prolactinoma: an ultrastructural and immunoelectron microscopical study.
Zhou XJ; Zhang TH; Yu YQ; Wang FA
J Tongji Med Univ; 1990; 10(2):83-7. PubMed ID: 2213957
[TBL] [Abstract][Full Text] [Related]
39. Pituitary tumors in children: clinical analysis of 21 cases.
Mehrazin M
Childs Nerv Syst; 2007 Apr; 23(4):391-8. PubMed ID: 17143643
[TBL] [Abstract][Full Text] [Related]
40. Molecular Biology of Pituitary Adenomas.
Faltermeier CM; Magill ST; Blevins LS; Aghi MK
Neurosurg Clin N Am; 2019 Oct; 30(4):391-400. PubMed ID: 31471046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
